RxDoctor Payments Data

Julie Blatt

Pediatric Hematology-Oncology · Chapel Hill, NCNPI 1427146687

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $900 of the $1,150 with a category attached, or 78.3%. Bayer accounts for 78.3% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for pediatric hematology-oncology clinicians in NC, where the typical reported total is $1,560.

$1,150in general payments, 2019–2025

Across 2 payments — averaging $575.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$900
  • AstraZeneca$250
$4,561,127in research payments, 2019–2025

Across 6 payments — averaging $760,188 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$4.6M

What the payments were for

  • Consulting fees$90078%
  • Speaking & faculty fees$25022%

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer1$900
AstraZeneca1$250

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,150 in reported general payments places this provider in the 45th percentile of 57 pediatric hematology-oncology providers in North Carolina.

See all pediatric hematology-oncology providers in North Carolina

Other pediatric hematology-oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →